In Defense of Butch Bodies
There’s power in a viral clapback. But what of the already-marginalized people whose identities again become a public punchline?
There’s power in a viral clapback. But what of the already-marginalized people whose identities again become a public punchline?
NEW YORK — The 2024 NAB Show New York concluded, solidifying its place as the must-attend East Coast event for not only broadcast, media and entertainment professionals but for anyone creating content across various industries. With more than 12,000 attendees, some 250 Exhibitors, 50 of which are first-timers, and 20 new product launches, the Show offered a comprehensive look at the latest trends and innovations shaping the industry. Held at the Jacob K. Javits Convention Center, the Show’s Q4 timing provided a pivotal opportunity for professionals to explore end-of-year purchases and prepare strategic decisions for 2025.
BELGRADE, 8 April 2016 - On the occasion of International Roma Day, the Delegation of the European Union to Serbia, the United Nations Country Team in Serbia, the OSCE Mission to Serbia and the Council of Europe Office in Belgrade reaffirm our strong commitment to equality and non-discrimination.
Today, the Romani community, Europe's largest ethnic minority, still experiences multiple discrimination and marginalisation in countries throughout Europe, including Serbia. Roma remain one of the most vulnerable groups; they continue to face difficult living conditions and discrimination in access to social protection, health, employment and adequate housing, as stated in reports by both relevant international mechanisms and independent bodies of the Republic of Serbia.
Thousands of Roma represent the most vulnerable and marginalised among the population of internally displaced, still facing obstacles in accessing rights and durable solutions.
International and European human rights standards clearly provide for equality before the law and prohibit discrimination on all grounds, including ethnicity. The realisation of Roma inclusion will reinforce everyday democracy and the rule of law. It is the only way to reach a society based on the principle of equality of opportunity where everyone has the right to participate and to be heard.
On this day, we therefore call on all relevant stakeholders to pursue with determination
Roma inclusion policies in Serbia, pursuant to the recent adoption of a new Strategy of Social Inclusion of Roma for the Period from 2015-2025 and the Action Plan for Realization of Rights of National Minorities by the Government of Serbia.
The Delegation of the European Union, the Council of Europe Office in Belgrade, the OSCE Mission to Serbia and the United Nations Country Team in Serbia remain committed to improving the lives of Roma in Serbia and ensuring that their fundamental rights are respected, and to supporting our Serbian partners in this endeavour.
International Roma Day is celebrated annually on April 8, in commemoration of the 1971 founding of the International Romani Union, the first major international Romani civic initiative.
Statistical information on Roma in Serbia
For more information & media inquiries please contact:
Aleksandra Stamenkovic, United Nations Country Team Communications Expert, email: aleksandra.stamenkovic@one.un.org, Phone +381 11 415 5314
Nadezda Dramicanin, Delegation of the EU to Serbia Communications Officer, e-mail: Nadezda.DRAMICANIN@eeas.europa.eu, Phone: +381 11 3083 200
Ivana Milatovic, OSCE National Political and Press Affairs Officer, e-mail: ppiu-serbia@osce.org, Phone +381 11 3606 151
Mona Alghaith, Council of Europe Office, Assistant to the Head of Office, e-mail: mona.alghaith@coe.int, Phone. +381 11 71 555 00
A memorandum of understanding signed on 19 May 2016 by the OSCE Office in Yerevan, the Ministry of Territorial Administration and Development, and the Union of Government Employees NGO aims to enhance the transparency and accountability of the community civil service of Armenia’s municipalities, local self-government bodies, and to improve relevant legislation, bringing it in line with international standards to reduce corruption in public administration.
Initiatives will include professional and regular training on principles and international standards of integrity in civil service, corruption risks, detection and prevention of corruption, reforms to training and recruitment of community servants in the regions, identifying legislation containing corruption risks, and recommendations for systemic reform.
“We hope this joint endeavour will contribute to the government’s efforts in implementing the anti-corruption strategy and in promoting efficient and accountable governance in Armenia,” said the Head of the OSCE Office in Yerevan Ambassador Argo Avakov.
David Lokyan, Armenia’s Minister of Territorial Administration and Development underlined the importance of co-operation in promoting better civil and community service, integrity and accountability among the local authorities, legislation reform in ensuring high-quality public administration in line with international standards throughout the regions in Armenia.
The initiative builds on Office-supported activities to train civil servants; improve the civil and community service system, including recruitment, monitoring and attestation; and to mainstream integrity in the public administration. A series of training courses for civil servants were held by the Union of Armenia's Government Employees NGO with the support of the OSCE Office and in partnership with the Civil Service Council of Armenia.
Vache Kalashyan, Chairperson of the Union of Government Employees, said: "We enjoy continuous co-operation with the civil and community services sector and are happy to enhance knowledge of corruption risks, conflict of interest, integrity and strengthen civil servants’ impact in delivering accountable and high-quality services on behalf of the State.”
Between 2009 and 2015 more than 300 civil servants representing 35 different state services were trained with the OSCE Office’s support on integrity, anti-corruption and ethics.
BELGRADE, 8 April 2016 - On the occasion of International Roma Day, the Delegation of the European Union to Serbia, the United Nations Country Team in Serbia, the OSCE Mission to Serbia and the Council of Europe Office in Belgrade reaffirm our strong commitment to equality and non-discrimination.
Today, the Romani community, Europe's largest ethnic minority, still experiences multiple discrimination and marginalisation in countries throughout Europe, including Serbia. Roma remain one of the most vulnerable groups; they continue to face difficult living conditions and discrimination in access to social protection, health, employment and adequate housing, as stated in reports by both relevant international mechanisms and independent bodies of the Republic of Serbia.
Thousands of Roma represent the most vulnerable and marginalised among the population of internally displaced, still facing obstacles in accessing rights and durable solutions.
International and European human rights standards clearly provide for equality before the law and prohibit discrimination on all grounds, including ethnicity. The realisation of Roma inclusion will reinforce everyday democracy and the rule of law. It is the only way to reach a society based on the principle of equality of opportunity where everyone has the right to participate and to be heard.
On this day, we therefore call on all relevant stakeholders to pursue with determination
Roma inclusion policies in Serbia, pursuant to the recent adoption of a new Strategy of Social Inclusion of Roma for the Period from 2015-2025 and the Action Plan for Realization of Rights of National Minorities by the Government of Serbia.
The Delegation of the European Union, the Council of Europe Office in Belgrade, the OSCE Mission to Serbia and the United Nations Country Team in Serbia remain committed to improving the lives of Roma in Serbia and ensuring that their fundamental rights are respected, and to supporting our Serbian partners in this endeavour.
International Roma Day is celebrated annually on April 8, in commemoration of the 1971 founding of the International Romani Union, the first major international Romani civic initiative.
Statistical information on Roma in Serbia
For more information & media inquiries please contact:
Aleksandra Stamenkovic, United Nations Country Team Communications Expert, email: aleksandra.stamenkovic@one.un.org, Phone +381 11 415 5314
Nadezda Dramicanin, Delegation of the EU to Serbia Communications Officer, e-mail: Nadezda.DRAMICANIN@eeas.europa.eu, Phone: +381 11 3083 200
Ivana Milatovic, OSCE National Political and Press Affairs Officer, e-mail: ppiu-serbia@osce.org, Phone +381 11 3606 151
Mona Alghaith, Council of Europe Office, Assistant to the Head of Office, e-mail: mona.alghaith@coe.int, Phone. +381 11 71 555 00
If you’ve ever seen yourself through a thermal imaging camera, you’ll know that your body produces lots of heat. This is in fact a waste product of our metabolism. Every square foot of the human body gives off heat equivalent to about 19 matches per hour. Unfortunately, much of this heat simply escapes into the atmosphere. Wouldn’t it be great if we could harness it to produce energy? My research has shown this would indeed be possible. My colleagues and I are discovering ways of capturing and storing body heat for energy generation, using eco-friendly materials. The goal is to…
This story continues at The Next Web
Hosted by David and Nycci Nellis. On today’s show: • Jon Krinn, CEO of WineLAIR in the West End, the U.S. outpost of the European WineBANK network, a gathering place that offers members access to…
The post Foodie and the Beast – Dec. 18, 2022 first appeared on Federal News Network.
Hosted by Nycci Nellis. On today’s show: · Mary Ann Mohanraj, clinical associate professor of fiction and literature at the University of Illinois at Chicago. She recently published the first vegan Sri Lankan American cookbook,…
The post Foodie and the Beast – Jan. 8, 2023 first appeared on Federal News Network.
The reports of multistakeholder Internet governance's demise are greatly exaggerated. This article explores the dual nature of multistakeholderism: its evolving, sometimes contentious practice as the "First Body," and its enduring principle of actor plurality as the "Second Body." Despite criticism and challenges, multistakeholderism remains crucial for a resilient, non-state-led Internet, underscoring the need to adapt and uphold its foundational pluralism.
The Southern Arizona Arts & Cultural Alliance in partnership with Tucson Foodie, hosted the first Oro Valley Fall Foodie & Art Festival on Oct. 26 and Oct. 27 at the Oro Valley Marketplace. The event featured arts, food and fall festivities…
With all the costumes and candy and scary good fun, Halloween is one of the most enjoyable holidays. Here are some items that we think will make your spooky parties even more fun, and we begin with a monstrously good soundtrack
The Candy Whips about their new angular synthpop album Artificial Melodies that is out today via Kitten Robot Records
Recently Donald Trump tweeted the word "TREASON?" in light of the New York Times op ed that was published on Wednesday. The article was supposedly written by someone within the Trump Administration, calling themselves part of the "resistance."
After Trump's "treason" tweet, people on Twitter began making their own amusing parodies, which you can read below!
Canan Moodie used his start against Scotland to show that he is about far more than just pace out wide and aerial ability.
Reliable, specific polyclonal and monoclonal antibodies are important tools in research and medicine. However, the discovery of antibodies against their targets in their native forms is difficult. Here, we present a novel method for discovery of antibodies against membrane proteins in their native configuration in mammalian cells. The method involves the co-expression of an antibody library in a population of mammalian cells that express the target polypeptide within a natural membrane environment on the cell surface. Cells that secrete a single-chain fragment variable (scFv) that binds to the target membrane protein thereby become self-labeled, enabling enrichment and isolation by magnetic sorting and FRET-based flow sorting. Library sizes of up to 109 variants can be screened, thus allowing campaigns of naïve scFv libraries to be selected against membrane protein antigens in a Chinese hamster ovary cell system. We validate this method by screening a synthetic naïve human scFv library against Chinese hamster ovary cells expressing the oncogenic target epithelial cell adhesion molecule and identify a panel of three novel binders to this membrane protein, one with a dissociation constant (KD) as low as 0.8 nm. We further demonstrate that the identified antibodies have utility for killing epithelial cell adhesion molecule–positive cells when used as a targeting domain on chimeric antigen receptor T cells. Thus, we provide a new tool for identifying novel antibodies that act against membrane proteins, which could catalyze the discovery of new candidates for antibody-based therapies.
Some cases of chylomicronemia are caused by autoantibodies against glycosylphosphatidylinositol-anchored HDL binding protein 1 (GPIHBP1), an endothelial cell protein that shuttles LPL to the capillary lumen. GPIHBP1 autoantibodies prevent binding and transport of LPL by GPIHBP1, thereby disrupting the lipolytic processing of triglyceride-rich lipoproteins. Here, we review the "GPIHBP1 autoantibody syndrome" and summarize clinical and laboratory findings in 22 patients. All patients had GPIHBP1 autoantibodies and chylomicronemia, but we did not find a correlation between triglyceride levels and autoantibody levels. Many of the patients had a history of pancreatitis, and most had clinical and/or serological evidence of autoimmune disease. IgA autoantibodies were present in all patients, and IgG4 autoantibodies were present in 19 of 22 patients. Patients with GPIHBP1 autoantibodies had low plasma LPL levels, consistent with impaired delivery of LPL into capillaries. Plasma levels of GPIHBP1, measured with a monoclonal antibody–based ELISA, were very low in 17 patients, reflecting the inability of the ELISA to detect GPIHBP1 in the presence of autoantibodies (immunoassay interference). However, GPIHBP1 levels were very high in five patients, indicating little capacity of their autoantibodies to interfere with the ELISA. Recently, several GPIHBP1 autoantibody syndrome patients were treated successfully with rituximab, resulting in the disappearance of GPIHBP1 autoantibodies and normalization of both plasma triglyceride and LPL levels. The GPIHBP1 autoantibody syndrome should be considered in any patient with newly acquired and unexplained chylomicronemia.
Ankylosing Spondylitis (AS) is a common, inflammatory rheumatic disease, which primarily affects the axial skeleton and is associated with sacroiliitis, uveitis and enthesitis. Unlike other autoimmune rheumatic diseases, such as rheumatoid arthritis or systemic lupus erythematosus, autoantibodies have not yet been reported to be a feature of AS. We therefore wished to determine if plasma from patients with AS contained autoantibodies and if so, characterize and quantify this response in comparison to patients with Rheumatoid Arthritis (RA) and healthy controls. Two high-density nucleic acid programmable protein arrays expressing a total of 3498 proteins were screened with plasma from 25 patients with AS, 17 with RA and 25 healthy controls. Autoantigens identified were subjected to Ingenuity Pathway Analysis in order to determine patterns of signalling cascades or tissue origin. 44% of patients with Ankylosing Spondylitis demonstrated a broad autoantibody response, as compared to 33% of patients with RA and only 8% of healthy controls. Individuals with AS demonstrated autoantibody responses to shared autoantigens, and 60% of autoantigens identified in the AS cohort were restricted to that group. The AS patients autoantibody responses were targeted towards connective, skeletal and muscular tissue, unlike those of RA patients or healthy controls. Thus, patients with AS show evidence of systemic humoral autoimmunity and multispecific autoantibody production. Nucleic Acid Programmable Protein Arrays constitute a powerful tool to study autoimmune diseases.
Antibodies play essential roles in both diagnostics and therapeutics. Epitope mapping is essential to understand how an antibody works and to protect intellectual property. Given the millions of antibodies for which epitope information is lacking, there is a need for high-throughput epitope mapping. To address this, we developed a strategy, Antibody binding epitope Mapping (AbMap), by combining a phage displayed peptide library with next generation sequencing. Using AbMap, profiles of the peptides bound by 202 antibodies were determined in a single test, and linear epitopes were identified for >50% of the antibodies. Using spike protein (S1 and S2)-enriched antibodies from the convalescent serum of one COVID-19 patient as the input, both linear and conformational epitopes of spike protein specific antibodies were identified. We defined peptide-binding profile of an antibody as the Binding Capacity (BiC). Conceptually, the BiC could serve as a systematic and functional descriptor of any antibody. Requiring at least one order of magnitude less time and money to map linear epitopes than traditional technologies, AbMap allows for high-throughput epitope mapping and creates many possibilities.
To identify novel autoantibodies of Takayasu arteritis (TAK) using HuProt array-based approach. A two-phase approach was adopted. In Phase I, serum samples collected from 40 TAK patients, 15 autoimmune disease patients, and 20 healthy subjects were screened to identify TAK-specific autoantibodies using human protein (HuProt) arrays. In Phase II, the identified candidate autoantibodies were validated with TAK-focused arrays using an additional cohort comprised of 109 TAK patients, 110 autoimmune disease patients, and 96 healthy subjects. Subsequently, the TAK-specific autoantibodies validated in Phase II were further confirmed using Western blot analysis. We identified and validated eight autoantibodies as potential TAK-specific diagnostic biomarkers, including anti-SPATA7, -QDPR, -SLC25A2, -PRH2, -DIXDC1, -IL17RB, -ZFAND4, and -NOLC1 antibodies, with AUC of 0.803, 0.801, 0.780, 0.696, 0.695, 0.678, 0.635 and 0.613, respectively. SPATA7 could distinguish TAK from healthy and disease controls with 73.4% sensitivity at 85.4% specificity, while QDPR showed 71.6% sensitivity at 86.4% specificity. SLC25A22 showed the highest sensitivity of 80.7%, but at lower specificity of 67.0%. In addition, PRH2, IL17RB and NOLC1 showed good specificities of 88.3%, 85.9% and 86.9%, respectively, but at lower sensitivities (<50%). Finally, DIXDC1 and ZFAND4 showed moderate performance as compared with the other autoantibodies. Using a decision tree model, we could reach a specificity of 94.2% with AUC of 0.843, a significantly improved performance as compared to that by each individual biomarker. The performance of three autoantibodies, namely anti-SPATA7, -QDPR and -PRH2, were successfully confirmed with Western blot analysis. Using this two-phase strategy, we identified and validated eight novel autoantibodies as TAK–specific biomarker candidates, three of which could be readily adopted in a clinical setting.
Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically approved bsAbs have entered the clinic internationally since 2022. Hence, research on biomedical imaging of various radiolabeled bsAb scaffolds may serve to improve patient selection for bsAb therapy. Here, we provide a comprehensive overview of recent advances in radiolabeled bsAbs for imaging via PET or SPECT. We compare direct targeting and pretargeting approaches in preclinical and clinical studies in oncologic research. Furthermore, we show preclinical applications of imaging bsAbs in neurodegenerative diseases. Finally, we offer perspectives on the future directions of imaging bsAbs based on their challenges and opportunities.